UKHSA (UK) · Jun 9, 2026
Correspondence: National flu immunisation programme plan 2026 to 2027
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Global Health · page 25
UK, EU & international health agencies
DHSC (UK) · Jun 9, 2026
Official Statistics: Adult social care client level data, England: quarterly update to December 2025
Official statistics in development on insights from client level data from local authorities, including information on assessments and long-term support.
DHSC (UK) · Jun 9, 2026
Official Statistics: Adult social care client level data, England: quarterly update to September 2025
Official statistics in development on insights from client level data from local authorities, including information on assessments and long-term support.
DHSC (UK) · Jun 8, 2026
Unpaid carers and parents of seriously ill children could get new rights under Government proposals
Government consults on new rights for unpaid carers and parents of seriously ill children, including whether paid leave could improve job opportunities.
DHSC (UK) · Jun 8, 2026
Millions to get faster eye care on the high street
Government invests £20 million to digitise referrals from the high street directly and digitally into NHS hospital eye services.
UKHSA (UK) · Jun 8, 2026
Training and events: UKHSA Knowledge and Library Services
Knowledge and Library Services provide a range of information skills training for eligible staff. Training is available in group or one-to-one settings.
DHSC (UK) · Jun 8, 2026
Embedding co-design and participation in early years services
Policy Lab worked with the Department of Health and Social Care to develop a co-design toolkit enabling parents and carers to shape early years services.
MHRA (UK) · Jun 8, 2026
Decision: Advertising investigations: May 2026
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
MHRA (UK) · Jun 8, 2026
Clinical trials for medicines: modifying a clinical trial approval
Guidance on the various types of modifications that can be made to a clinical trial approval.
ECDC Epi Updates · Jun 8, 2026
MERS-CoV worldwide overview
Since the beginning of 2026, and as of 2 July 2026, two MERS cases, including one fatality, have been reported in Saudi Arabia.
MHRA (UK) · Jun 8, 2026
Field Safety Notices: 1-5 June 2026
List of Field Safety Notices for 1-5 June 2026
UKHSA (UK) · Jun 8, 2026
Guidance: Carbon monoxide (CO): antenatal checks algorithm for midwives
An algorithm for midwives to help diagnose carbon monoxide poisoning in pregnant women and offer advice for pregnant women in the event of exposure.
DHSC (UK) · Jun 8, 2026
New guidance on screen use for children aged 5–16
First-ever government guidance on healthy screen use for children aged 5–16 .
MHRA (UK) · Jun 8, 2026
Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28
Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.
MHRA (UK) · Jun 8, 2026
Find product information about medicines
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
UKHSA (UK) · Jun 8, 2026
Official Statistics: Weekly all-cause mortality surveillance: week ending 5 July 2026
How the actual number of deaths in England compare with expected numbers for each week.
UKHSA (UK) · Jun 8, 2026
Accredited official statistics: Quarterly Epidemiological Commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection, data up to January to March 2026
Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa ( P. aeruginoa), Klebsiella species (Klebsiella spp.)), and Clostridioides difficile (C. difficile) infection.
UKHSA (UK) · Jun 8, 2026
Official Statistics: Respiratory syncytial virus (RSV) older adults vaccination coverage in England: May 2026
Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for older adults.
MHRA (UK) · Jun 8, 2026
Decision: Medical devices given exceptional use authorisations
List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.
DHSC (UK) · Jun 8, 2026
Research: Skin cancer risks from sunbed use and their control
COMARE’s 21st report reviews scientific evidence on skin cancer risks and other health effects from sunbed use and considers options for control of their use.
NHS England · Jun 7, 2026
500,000 NHS staff to get new artificial intelligence tools to help free up more time for patients
More than half a million NHS staff are being given access to new artificial intelligence (AI) tools that could free up an average of 2 days every month from admin duties, freeing up more time for the duties that matter most for patients and staff. NHS England announced today that it is significantly accelerating AI […]
MHRA (UK) · Jun 5, 2026
Decision: Human and veterinary medicines: register of licensed manufacturing sites
The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only.
MHRA (UK) · Jun 5, 2026
Notice: Register of brokers authorised to deal in human medicines
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
MHRA (UK) · Jun 5, 2026
Decision: Medicines: new manufacturing and wholesale dealer licences
List of sites granted a manufacturer or wholesale dealer licence.